Who has invested in QureBio?

Efung Capital are named among the investors backing QureBio.

QureBio Funding: $45M Raised, Series C (2025)

QureBio funding overview

QureBio is based in Shanghai, China. QureBio has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2025. The round record for QureBio runs through 2025; nothing later has been disclosed. Investors on record include Efung Capital.

QureBio at a glance

Total raised: $45M
Latest round: Series C
Latest round date: June 2025
Headquarters: Shanghai, China
Notable investors: Efung Capital

Frequently asked about QureBio funding

How much has QureBio raised?: QureBio has raised $45M in total disclosed funding across the rounds on record.
Who has invested in QureBio?: Efung Capital are named among the investors backing QureBio.
What was the latest QureBio funding round?: The most recent disclosed round is a Series C, announced in June 2025.
Where is QureBio based?: QureBio is based in Shanghai, China.
When did QureBio last raise?: The last disclosed QureBio round closed in June 2025 at Series C.

Round data for QureBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

QureBio Funding: $45M Raised, Series C (2025)

QureBio funding overview

QureBio at a glance

Frequently asked about QureBio funding

Companies related to QureBio (23)

Browse related funding lists (5)